Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (7): 32-35.doi: 10.6040/j.issn.1671-7554.0.2022.0467

Previous Articles     Next Articles

Patient education and proper management of adenomyosis

YI Xiaofang1,2,3, HUANG Jihua1   

  1. 1. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China;
    2. Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai 200011, China;
    3. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China
  • Published:2022-07-27

RichHTML

5

PDF (PC)

512

Abstract: Adenomyosis, one of the chronic gynecological diseases manifested by dysmenorrhea, heavy menstrual bleeding or infertility, negatively impacts the health of women of childbearing age. Patient education and proper management are important components of quality patient care. Advancement in digital medicine brings innovation in patient education materials and modalities. This review aims to strengthen ‘patient-centered’ value and increase patients knowledge on adenomyosis as well as compliance on management. Specific advice is provided to improve patients self-evaluation on the menstrual health and fertility, supplemented by well-designed clinical trials. In addition, the supporting roles of medical practitioners, partners, patients and society need to be pulled together to promote better outcome in long-term management of adenomyosis.

Key words: Adenomyosis, Patient education, Menstrual health management, Fertility preserving management, Four facets of support

CLC Number: 

  • R711.74
[1] 冷金花. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
[2] Yu O, Schulze-Rath R, Grafton J, et al. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015 [J]. Am J Obstet Gynecol, 2020, 223(1): 94.e1-94.e10.
[3] 宁吉喆. 第七次全国人口普查主要数据情况[J]. 中国统计, 2021(5): 4-5.
[4] Okazaki K, Oka F, Ishihara H, et al. Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases [J]. BMC Neurol, 2018, 18(1): 166.
[5] Bourdon M, Oliveira J, Marcellin L, et al. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles [J]. Hum Reprod, 2021, 36(2): 349-357.
[6] Yajima R, Kido A, Kurata Y, et al. Diffusion-weighted imaging of uterine adenomyosis: correlation with clinical backgrounds and comparison with malignant uterine tumors [J]. J Obstet Gynaecol Res, 2021, 47(3): 949-960.
[7] Tellum T, Nygaard S, Skovholt EK, et al. Development of a clinical prediction model for diagnosing adenomyosis [J]. Fertil Steril, 2018, 110(5): 957-964.
[8] Liu X, Ding D, Ren Y, et al. Transvaginal elastosonography as an imaging technique for diagnosing adenomyosis [J]. Reprod Sci, 2018, 25(4): 498-514.
[9] Xie M, Yu H, Zhang X, et al. Elasticity of adenomyosis is increased after GnRHa therapy and is associated with spontaneous pregnancy in infertile patents [J]. J Gynecol Obstet Hum Reprod, 2019, 48(10): 849-853.
[10] 郎景和, 冷金花, 邓姗, 等. 左炔诺孕酮宫内缓释系统临床应用的中国专家共识[J]. 中华妇产科杂志, 2019, 54(12): 815-825.
[11] Takamura M, Koga K, Harada M,et al. A case of hemorrhagic shock occurred during dienogest therapy for uterine adenomyosis [J]. J Obstet Gynaecol Res, 2020, 46(12): 2696-2700.
[12] Huang R, Li X, Jiang H, et al. Barriers to self-management of patients with adenomyosis: a qualitative study [J]. Nurs Open, 2022, 9(2): 1086-1095.
[13] de Bruijn AM, Smink M, Hehenkamp WJK, et al. Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire [J]. Cardiovasc Intervent Radiol, 2017, 40(9): 1344-1350.
[14] Cheung VY. Current status of high-intensity focused ultrasound for the management of uterine adenomyosis [J]. Ultrasonography, 2017, 36(2): 95-102.
[15] Kobayashi H, Imanaka S. Proposal for developing treatment algorithms of women with symptomatic adenomyosis: a single-center experience [J]. J Obstet Gynaecol Res, 2021, 47(9): 3257-3268.
[16] Alfonsin MM, Chapon R, de Souza CAB, et al. Correlations among algometry, the visual analogue scale, and the numeric rating scale to assess chronic pelvic pain in women [J]. Eur J Obstet Gynecol Reprod Biol X, 2019, 3: 100037. doi: 10.1016/j.eurox.2019.100037.
[17] Spence M, de Repentigny K, Bowman M, et al. Validation of the pictorial blood loss assessment chart using modern sanitary products [J]. Haemophilia, 2021, 27(5): e632-e635.
[18] 中国医师协会妇产科医师分会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症诊治指南(第三版)[J]. 中华妇产科杂志, 2021, 56(12): 812-824.
[19] Soave I, Wenger JM, Pluchino N, et al. Treatment options and reproductive outcome for adenomyosis-associated infertility [J]. Curr Med Res Opin, 2018, 34(5): 839-849.
[20] Kishi Y, Yabuta M, Taniguchi F. Who will benefit from uterus-sparing surgery in adenomyosis-associated subfertility? [J]. Fertil Steril, 2014, 102(3): 802-807.
[21] Won S, Hwang JY, Lee N, et al. Anti-Müllerian hormone level may predict successful pregnancy after adenomyomectomy in patients with infertility due to adenomyosis [J]. Medicine(Baltimore), 2021, 100(21): e26075. doi: 10.1097/MD.0000000000026075.
[22] Guo SW, Groothuis PG. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? [J]. Hum Reprod Update, 2018, 24(5): 577-598.
[23] de Bruijn AM, Lohle PN, Huirne JA, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA Trial [J]. JMIR Res Protoc, 2018, 7(3): e47. doi: 10.2196/resprot.8512.
[24] Latif S, Wattar BHA, Balachandren N, et al. Effectiveness of modified downregulation for women with moderate and severe adenomyosis of the uterus prior to frozen thawed embryo transfer(MODA)study protocol: a pragmatic randomised-controlled trial [J]. BMJ Open, 2021, 11(10): e050248. doi: 10.1136/bmjopen-2021-050248.
[25] Nelsen LM, Lenderking WR, Pokrzywinski R, et al. Experience of symptoms and disease impact in patients with adenomyosis [J]. Patient, 2018, 11(3): 319-328.
[1] Guoyun WANG,Zangyu PAN. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55.
[2] Lei YAN,Zijiang CHEN. Treatment of adenomyosis complicated with infertility [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 43-47.
[3] Guowei TAO,Fang WANG,Xiangyi DONG,Yaxuan XU,Linli ZHAO,Beibei HU. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65.
[4] AILI Aixingzi,Zhengyu GUO,Xiaofei ZHANG. Latest research advances of high intensity focused ultrasound treatment for adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 36-42.
[5] ZHANG Xinmei, XU Ping. Surgical treatment strategies of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 26-31.
[6] LENG Jinhua, SHI Jinghua. Clinical manifestations of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 1-5.
[7] PENG Chao, ZHOU Yingfang. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[8] GUO Sunwei, LIU Xishi. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19.
[9] XU Ge, LI Qing, ZHANG Cancan, TIAN Yongjie. Expressions and clinical significance of PARP-1 and HIF-1α in adenomyosis tissues and primary cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 55-61.
[10] GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86.
[11] WANG Bingyu, YANG Yang, CHAO Lan. Expression and role of toll-like receptor 4 in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 47-52.
[12] HUANG Yufei, YANG Yang, SHAO Qianqian, DENG Xiaohui, CHAO Lan. Expression and role of adenosine monophosphate dependent protein kinase in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 93-98.
[13] LIN Xueyan, LI Chunyan, HOU Xiaoman, TIAN Yongjie. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 36-40.
[14] WU Lukanxuan, ZHU Shan, YU Jinxi, LÜ Chunzi, LI Mingjiang. Expression and significance of programmed death-1 and its ligand PD-L1 in adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 90-96.
[15] LIU Jing, ZHANG Hui, YAN Lei, ZHAO Xing-bo, LI Ming-jiang. Expression and significance of RhoE／Rnd3 protein in adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 116-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[2] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[3] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[4] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[5] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[6] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[7] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[8] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[9] GUO Zhihua, ZHAO Daqing, XING Yuan, WANG Wei, LIANG Leping, YANG Jing, ZHAO Qianqian. Single-stage end-to-end anastomosis in the management of severe cervical tracheal stenosis[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 72 -76 .
[10] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd